GlaxoSmithKline PLC (GSK) Social Stream
Glaxosmithkline Plc (GSK) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Glaxosmithkline Plc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
GSK's average price target has moved up $1.99 over the prior 70 days.
Over the past 129 days, GSK's average upside potential has been 12.12%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GSK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 90 days, GSK's average broker recommendation rating improved by 0.04.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GSK as an investment opportunity.
- GSK has a greater upside potential (average analyst target price relative to current price) than 44.72% of Pharmaceutical Products stocks.
- In terms of how Glaxosmithkline Plc fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than 23.13% of that group.
- Glaxosmithkline Plc's number of analysts covering the stock is greater than 123.71% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, Glaxosmithkline Plc's average analyst price target is higher than 178.09% of them.
What is the outlook for GSK? Use POWR Ratings for clearer insight into price direction.